evidencegaps
Primary study · included by 1 review

The Safety and Efficacy of Neoadjuvant Camrelizumab Plus Chemotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Retrospective Study.

Yin 2022 · Yin Guo-Qiang, Li Zu-Lei, Li Dong · Cancer management and research · 2022

Included by

The Efficacy and Safety of Neoadjuvant Immunotherapy in Pan-Squamous Cell Carcinomas: A Meta-Analysis of Esophageal, Head and Neck, Cervical, Lung, Cutaneous, and Oral Squamous Cell Carcinomas.
Non-Cochrane · intervention · 2026 · cited as Yin 2022 · Supplementary Table S1; reference list

The review does not say which of its outcomes this study informs.

1 including review in total.